• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Truveta Data used in new study shows women and Black patients less likely to receive catheter-based treatment for pulmonary embolism

Truveta Data used in new study shows women and Black patients less likely to receive catheter-based treatment for pulmonary embolism

by Truveta staff | May 13, 2024 | Research

Recently, researchers presented new insights from a continued analysis of the REAL-PE study at the Society for Cardiovascular Angiography and Interventions (SCAI) 2024 meeting. To address a lack of sufficient clinical guidance on how to best treat pulmonary embolism...
10 Truveta Research insights & publications of 2023

10 Truveta Research insights & publications of 2023

by Truveta staff | Dec 15, 2023 | Research

As 2023 draws to a close and we reflect on a busy and exciting year for Truveta, something that stands out is the breadth and depth of research Truveta Research has been able to produce using Truveta Data and Truveta Studio. From studying new Alzheimer’s disease...
Trends in prescriptions following venous stent placement

Trends in prescriptions following venous stent placement

by Truveta staff | Oct 10, 2023 | Research, Research Insights

The aim of this analysis was to compare different prescription trends post-venous stenting and set the foundation for future research.  We identified a disparity showing that certain populations are less likely to receive prescriptions for medications within 30 days...

Share this


Recent posts

  • Truveta leads a new era in cancer research with the most complete, representative, and timely real-world data on all cancers
  • Top 5 takeaways from Truveta Symposium 2025
  • Women’s health: Pain medication remains rare for women receiving IUDs

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Get started

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Interested in learning more?

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice